J. Debenham

发表

Glutathione S-Transferase Catalyzed Desulfonylation of a Sulfonylfuropyridine

Sanjeev Kumar, G. Doss, T. F. Walsh, 2010, Drug Metabolism and Disposition.

GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy[S]

Margaret S. Wu, M. Erion, Vinit Shah, 2017, Journal of Lipid Research.

Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.

L. Shearman, Richard Z. Chen, R. Ball, 2010, Journal of medicinal chemistry.

Two New Orthogonal Amine-Protecting Groups that can be Cleaved under Mild or Neutral Conditions

R. Madsen, B. Fraser-Reid, J. Debenham, 1995 .

Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: synthesis and biological evaluation. Part 1.

L. Shearman, D. Marsh, Sanjeev Kumar, 2010, Bioorganic & medicinal chemistry letters.

Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation.

L. Shearman, T. Fong, X. Tong, 2009, Bioorganic & medicinal chemistry letters.

Preparation and characterization of arabinoxylan esters and arabinoxylan ester/cellulose ester polymer blends

P. Gatenholm, N. Buchanan, C. M. Buchanan, 2003 .

Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation.

L. Shearman, M. Goulet, T. Fong, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists.

J. Chen, L. V. D. van der Ploeg, L. Shearman, 2005, Bioorganic & medicinal chemistry letters.

Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists.

D. Macintyre, L. V. D. van der Ploeg, L. Shearman, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of Functionalized 1,8‐Naphthyridinones and Their Evaluation as Novel, Orally Active CB1 Receptor Inverse Agonists.

J. Debenham, 2006 .

Debenzylation of complex oligosaccharides using ferric chloride

B. Fraser-Reid, J. Debenham, R. Rodebaugh, 1996 .

Recent Advances in N‐Protection for Amino Sugar Synthesis

B. Fraser-Reid, J. Debenham, R. Rodebaugh, 1997 .

Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.

Jeffrey T. Kuethe, J. Demartino, E. Sherer, 2016, Journal of medicinal chemistry.

Total syntheses of (-)-haemanthidine, (+)-pretazettine, and (+)-tazettine.

S. Baldwin, J. Debenham, J. S. Debenham, 2000, Organic letters.

Synthesis of Carbon-Linked Glycopeptides through Catalytic Asymmetric Hydrogenation

E. Toone, M. Burk, J. Debenham, 1997 .

N-Tetrachlorophthaloyl (TCP) for ready protection/deprotection of amino sugar glycosides.

B. Fraser-Reid, J. Debenham, S. Debenham, 1996, Bioorganic & medicinal chemistry.

Nodulation Factors: A Strategy for Convergent Assembly of a Late-Stage Key Intermediate Illustrated by the Total Synthesis of NodRf-III (C18:1) (MeFuc).

B. Fraser-Reid, J. Debenham, R. Rodebaugh, 1996, The Journal of organic chemistry.

Tetrachlorophthaloyl as a Versatile Amine Protecting Group.

B. Fraser-Reid, J. Debenham, 1996, The Journal of organic chemistry.

TCP Building Blocks for Oligosaccharide Synthesis: Progress Towards the Synthesis of Nodulation Factors

B. Fraser-Reid, J. Debenham, R. Rodebaugh, 1997 .

Advances in cellulose ester performance and application

Paul A. Rundquist, B. Seiler, Charles Michael Buchanan, 2001 .

TCP- and Phthalimide-Protected n-Pentenyl Glucosaminide Precursors for the Synthesis of Nodulation Factors As Illustrated by the Total Synthesis of NodRf-III (C18:1, MeFuc)

B. Fraser-Reid, J. Debenham, R. Rodebaugh, 1997 .

Methods for Debrominating 4,5-Dibromopentanyl Glycosides

B. Fraser-Reid, J. Debenham, J. Merritt, 1996 .

Methods for Debrominating 4,5-Dibromopentanyl Glycosides.

B. Fraser-Reid, J. Debenham, J. Merritt, 1996 .

Bromination of Alkenyl Glycosides with Copper(II) Bromide and Lithium Bromide: Synthesis, Mechanism, and DFT Calculations.

J. Snyder, B. Fraser-Reid, J. Debenham, 1999, The Journal of organic chemistry.

Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes.

F. Ujjainwalla, E. Sherer, A. Howard, 2016, ACS medicinal chemistry letters.

Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.

Shirly Pinto, J. Lisnock, M. Garcia-Calvo, 2013, Bioorganic & medicinal chemistry letters.

Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists.

A. Crespo, E. Tozzo, F. Ujjainwalla, 2017, ACS medicinal chemistry letters.